Universal Starch Chem Allied Ltd

Universal Starch Chem Allied Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 31 December 2025, primarily driven by a shift in technical indicators. Despite persistent fundamental challenges and underwhelming financial trends, the stock’s technical outlook has improved from bearish to mildly bearish, prompting a reassessment of its market stance. This article analyses the four key parameters—Quality, Valuation, Financial Trend, and Technicals—that influenced this rating change.

Universal Starch Chem Allied Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 11 Aug 2025, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 25 December 2025, providing investors with the latest perspective on the company’s position in the market.

Universal Starch Chem Allied has reached a new 52-week low of Rs.116, marking a significant decline amid a volatile trading session. The stock's recent performance reflects ongoing pressures within the Other Agricultural Products sector, with the share price moving below all key moving averages and underperforming its sector peers.

Universal Starch has experienced a revision in its market evaluation, reflecting shifts in its fundamental and technical outlook. The company’s recent assessment highlights a complex interplay of valuation appeal, subdued financial momentum, and technical indicators that have influenced investor sentiment.

Universal Starch Chem Allied has reached a new 52-week low, with its stock price touching Rs.120 today. This marks a significant decline amid a series of consecutive falls, reflecting ongoing pressures within the company’s financial and market performance.

Universal Starch Chem Allied has reached a new 52-week low of Rs.120, marking a significant decline amid a sustained period of negative returns. The stock has been under pressure for the past five trading sessions, reflecting ongoing challenges within the company and the broader sector.

Universal Starch Chem Allied has reached a new 52-week low of Rs.125, marking a significant decline in its stock price amid a series of consecutive falls over the past four days. This development comes despite a broadly positive market environment, with the Sensex trading near its 52-week high.

Universal Starch Chem Allied has reached a new 52-week low, closing at Rs.125 today. This marks a significant price level for the stock, which has experienced a sustained decline over recent sessions amid broader market gains.

Universal Starch Chem Allied has reached a new 52-week low of Rs.125, marking a significant decline in its stock price amid a series of consecutive falls over the past four days. This development comes despite a broadly positive market environment, with the Sensex trading near its 52-week high.

Universal Starch Chem Allied has reached a new 52-week low of Rs.125, marking a significant decline amid a sustained downward trend over the past several days. The stock’s recent performance contrasts sharply with broader market gains, reflecting ongoing pressures within the company’s financial and operational metrics.

Universal Starch Chem Allied has reached a new 52-week low of Rs.128, marking a significant decline in its stock price amid a sustained period of negative returns and underperformance relative to its sector and benchmark indices.

Universal Starch Chem Allied has reached a 52-week low of Rs. 130, reflecting a significant decline in its stock performance. The stock has underperformed its sector and is trading below all major moving averages. Recent financial results indicate a decrease in net sales, contributing to its downward trend.

Universal Starch-Chem Allied Ltd., a micro-cap agricultural products company with a market capitalisation of ₹61.00 crores, posted a net profit of ₹0.76 crores in Q2 FY26, representing a dramatic turnaround from the ₹8.22 crores loss reported in the same quarter last year. However, the sequential momentum has stalled sharply, with the company sliding back into marginal profitability after posting ₹2.94 crores in Q4 FY25. The stock has responded to this mixed performance by declining 17.14% over the past year, significantly underperforming both the Sensex and its sector peers.